Auswirkungen des Therapiefortschritts am Beispiel MS

NeuroTransmitter 2026

View at publisher

Authors: Kathrin Pahmeier, Dominik Thomas, Anja Jane Niemann, Lara Kleinschmidt, Jürgen Wasem, Silke Neusser

DOI: 10.1007/s15016-025-4188-4

Cited by: 0

Fields of Study & Subjects

Multiple Sclerosis Research Studies Medical research and treatments Pharmaceutical Practices and Patient Outcomes